News New tool promises more accurate breast cancer diagnosis Zebra Medical Vision's new algorithm will "reduce misdiagnosis and false alarms."
News Teva buys US rights to Celltrion biosimilars Israeli firm buys rights to near-copies of Roche blockbusters.
News Pfizer's breast cancer drug step closer to EU approval Ibrance is already Pfizer's top oncology product.
Cancer Lilly’s wait for breast cancer data will help rivals Setback for Lilly as it looks to develop best-in-class product
Cancer Novartis’ breast cancer drug LEEO11 gains breakthrough statu... Drug will challenge Pfizer's Ibrance
News Relief for AZ as Truqap hits the spot in prostate cancer After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
